ABSCIENCES (EPA:AB) | WebDisclosure

Basculer en Français

11275	Companies
250523	Keywords
179127	Articles
136345	Press releases

Home
Companies
ABSCIENCES

PRESS RELEASE

published on 07/08/2024 at 07:56, 2 years 3 months ago

AB Science annonce des résultats positifs de son étude de Phase 2 évaluant le masitinib dans la Covid-19
AB Science annonce des résultats positifs de son étude de phase 2 évaluant le masitinib dans la COVID-19. Les analyses montrent un potentiel traitement prometteur pour les patients hospitalisés

COVID-19 Traitement Étude De Phase 2 AB Science Masitinib
BRIEF

published on 06/28/2024 at 12:36, 2 years 4 months ago

AB Science fait le point sur la demande d'autorisation du masitinib dans la SLA

Autorisation De Mise Sur Le Marché AB Science Masitinib EMA SLA
BRIEF

published on 06/28/2024 at 12:36, 2 years 4 months ago

AB Science provides an update on the application for authorization of masitinib in ALS

ALS AB Science Masitinib EMA Marketing Authorization
PRESS RELEASE

published on 06/28/2024 at 12:31, 2 years 4 months ago

AB Science fait le point sur la demande d'autorisation de mise sur le marché conditionnelle du masitinib dans la SLA
AB Science annonce un avis négatif sur la demande de mise sur le marché du masitinib dans la SLA et prévoit un réexamen du dossier. Détails sur les raisons et les prochaines étapes

AB Science Masitinib Sclérose Latérale Amyotrophique Autorisation Conditionnelle Réexamen Dossier
PRESS RELEASE

published on 06/28/2024 at 12:31, 2 years 4 months ago

AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS
AB Science receives negative opinion from CHMP on masitinib's conditional marketing authorization for ALS treatment but plans re-examination due to urgent patient need and safety considerations

AB Science Masitinib CHMP ALS Treatment Conditional Marketing Authorization
BRIEF

published on 06/27/2024 at 10:20, 2 years 4 months ago

AB Science - Résultats de l'Assemblée Générale Mixte du 26 juin 2024

Actionnaires Capital Social Assemblée Générale Resolutions AB Science
BRIEF

published on 06/27/2024 at 10:20, 2 years 4 months ago

AB Science - Results of the Combined General Meeting of June 26, 2024

Shareholders Share Capital Resolutions General Assembly AB Science
PRESS RELEASE

published on 06/27/2024 at 10:15, 2 years 4 months ago

AB Science - Résultats de l'Assemblée Générale Mixte du 26 juin 2024
Assemblée Générale Mixte de AB Science du 26 juin 2024 : toutes les résolutions ordinaires et extraordinaires adoptées sauf une. Actionnariat présent : 21.948.183 actions ordinaires et 38.495.615 droits de vote

Actionnaires Droits De Vote Assemblée Générale Resolutions AB Science
BRIEF

published on 05/17/2024 at 18:03, 2 years 5 months ago

Correction des Comptes Consolidés de AB Science pour 2023

Résultats Financiers Recherche Et Développement Comptes Consolidés AB Science Correction Comptable
BRIEF

published on 05/17/2024 at 18:03, 2 years 5 months ago

Correction of the Consolidated Accounts of AB Science for 2023

Financial Results Research And Development Consolidated Accounts AB Science Accounting Correction

Accesswire

Published on 11/04/2026 at 15:07, 10 minutes ago

Boron One Signs Second Binding Offtake Agreement for Sale of Boron Concentrates and Refined Boron Products
Published on 11/04/2026 at 15:00, 17 minutes ago

Vox Royalty Provides Update & Timeline for Assets Entering Production
Published on 11/04/2026 at 15:00, 17 minutes ago

ShelfieTech Announces Closing of Acquisition of Majority Interest in Aspect
Published on 11/04/2026 at 14:00, 1 hour 17 minutes ago

Adcore to Publish Third Quarter 2026 Results on November 10, 2026
Published on 11/04/2026 at 14:00, 1 hour 17 minutes ago

Dateline and US Government Seek Ninth Circuit Stay

View all ACCESSWIRE

EQS Group

Published on 11/04/2026 at 15:05, 12 minutes ago

New Research from Precisely and ASUG Reveals SAP Modernization Momentum as AI Adoption Accelerates and Migration Challenges Intensify
Published on 11/04/2026 at 15:05, 12 minutes ago

Synopsys Expands Access to Advanced Chip Design Capabilities Through European Chips Design Platform
Published on 11/04/2026 at 15:02, 15 minutes ago

Original-Research: Verve Group SE (von First Berlin Equity Research GmbH): Kaufen
Published on 11/04/2026 at 14:59, 18 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 11/04/2026 at 14:59, 18 minutes ago

Form 8.3 - The Vanguard Group, Inc.: RHI Magnesita N.V.

Les Echos

Published on 11/04/2026 at 15:02, 15 minutes ago

LNA Santé : Répartition de capital et des droits de vote attachés aux actions au 31/10/2026
Published on 11/04/2026 at 14:33, 44 minutes ago

Évolution mensuelle du 30 octobre 2026
Published on 11/04/2026 at 12:23, 2 hours 54 minutes ago

CDA - Actions et droits de vote au 31 octobre 2026
Published on 11/04/2026 at 11:56, 3 hours 20 minutes ago

Mersen: Number of shares and voting rights as of October 31, 2026
Published on 11/04/2026 at 11:56, 3 hours 20 minutes ago

Mersen : nombre d'actions et de droits de vote au 31 octobre 2026

View all LES ECHOS COMFI WIRE